Mariner’s Delcath Systems DCTH Stock Holding History

Mariner’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39,531	Closed	-$367K	–	3607
2026 Q1	$367K	Buy	+39,531	New	+$383K	﹤0.01%	2704

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mariner's DCTH Position: Q2 2026 in Review

Mariner sold out of Delcath Systems (DCTH) in Q2 2026, closing a stake of 39,531 shares — an estimated $367K sold.

Mariner first reported a position in DCTH in Q1 2026 and held it in 1 quarter. The position peaked at $367K in Q1 2026. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

Mariner reported no remaining Delcath Systems position as of Q2 2026 after selling out during the quarter.
Mariner sold 39,531 Delcath Systems shares in Q2 2026, an estimated $367K.
Mariner first reported a position in Delcath Systems in Q1 2026 and held it in 1 quarter.
Mariner's Delcath Systems position peaked at $367K in Q1 2026.
120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.